Show simple item record

dc.contributor.authorBubb, KJen_US
dc.contributor.authorAubdool, AAen_US
dc.contributor.authorMoyes, AJen_US
dc.contributor.authorLewis, Sen_US
dc.contributor.authorDrayton, JPen_US
dc.contributor.authorTang, Oen_US
dc.contributor.authorMehta, Ven_US
dc.contributor.authorZachary, ICen_US
dc.contributor.authorAbraham, DJen_US
dc.contributor.authorTsui, Jen_US
dc.contributor.authorHobbs, AJen_US
dc.date.accessioned2019-01-15T13:40:21Z
dc.date.available2018-11-15en_US
dc.date.issued2018-12-11en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/54649
dc.description.abstractBACKGROUND: Angiogenesis and vascular remodeling are complementary, innate responses to ischemic cardiovascular events, including peripheral artery disease (PAD) and myocardial infarction, which restore tissue blood supply and oxygenation; the endothelium plays a critical function in these intrinsic protective processes. C-type natriuretic peptide (CNP) is a fundamental endothelial signaling species that coordinates vascular homeostasis. Herein, we sought to delineate a central role for CNP in angiogenesis and vascular remodeling in response to ischemia. METHODS: The in vitro angiogenic capacity of CNP was examined in pulmonary microvascular endothelial cells (PMEC) and aortic rings isolated from wild type (WT), endothelium-specific CNP knockout (ecCNP-/-), and global natriuretic peptide receptor (NPR)-B-/- and NPR-C-/- animals, and in human umbilical vein endothelial cells (HUVEC). These studies were complemented by in vivo investigation of neovascularization and vascular remodeling following ischemia or vessel injury, and CNP/NPR-C expression & localization in tissue from patients with PAD. RESULTS: Clinical vascular ischemia is associated with reduced levels of CNP and its cognate NPR-C. Moreover, genetic or pharmacological inhibition of CNP and NPR-C, but not NPR-B, reduces the angiogenic potential of PMEC, HUVEC and isolated vessels ex vivo. Angiogenesis and remodeling are impaired in vivo in ecCNP-/- and NPR-C-/-, but not NPR-B-/-, mice; the detrimental phenotype caused by genetic deletion of endothelial CNP, but not NPR-C, can be rescued by pharmacological administration of CNP. The pro-angiogenic effect of CNP/NPR-C is dependent on activation of Gi, ERK1/2 and PI3Kγ/Akt at a molecular level. CONCLUSIONS: These data define a central (patho)physiological role for CNP in angiogenesis and vascular remodeling in response to ischemia and provide the rationale for pharmacological activation of NPR-C as an innovative approach to treating PAD and ischemic cardiovascular disorders.en_US
dc.languageengen_US
dc.language.isoenen_US
dc.relation.ispartofCirculationen_US
dc.subjectarteriogenesisen_US
dc.subjectnatriuretic peptide receptoren_US
dc.subjectvascular remodelingen_US
dc.titleEndothelial C-Type Natriuretic Peptide is a Critical Regulator of Angiogenesis and Vascular Remodeling.en_US
dc.typeArticle
dc.identifier.doi10.1161/CIRCULATIONAHA.118.036344en_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/30586761en_US
pubs.notesNot knownen_US
pubs.publication-statusPublished onlineen_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US
qmul.funderDelineating physiological and pathological regulatory roles for C-type natriuretic peptide in cardiac structure and function::British Heart Foundationen_US
qmul.funderDelineating physiological and pathological regulatory roles for C-type natriuretic peptide in cardiac structure and function::British Heart Foundationen_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record